Several aspects of the clinical pharmacology of propofol have been investigated in this study: dose requirements for the maintenance of anaesthesia, recovery from anaesthesia, cardiovascular response to anaesthesia and surgery, effects on coagulation and fibrinolysis, and the effects of anaesthesia and surgery on the normal neuroendocrine responses to stress. In addition, the incidence of pain on injection, and postoperative venous sequelae (phlebitis, thrombosis) over the first 24 h, were assessed.
PATIENTS AND METHODS

Patients
Patients (ASA I or II) undergoing body surface surgery gave their informed consent to participation in the study which was approved by both the Committee on Safety of Medicines, and the hospital Ethics Committee. The anaesthetic properties of diisopropyl phenol (propofol) were examined in two separate studies.
In the first study, patients were allocated to receive either propofol (n = 10) or Althesin (n = 10) (groups A and B) to supplement nitrous oxide in oxygen anaesthesia. In the second study, propofol (group C: n = 10) was compared with patients receiving thiopentone for the induction of anaesthesia, and nitrous oxide-oxygen-halothane (group D: n = 11) for the maintenance of anaesthesia. None of the patients had clinical evidence of hepatic or renal disease, nor was any receiving psychotropic drugs.
Patients were premedicated with morphine 0.15 mg kg" 1 and atropine 0.6 mg i.m. 1 h before the induction of anaesthesia. Anaesthesia was induced through an 18-SWG Venflon cannula placed in a vein in the dorsum of the hand. Apart from the induction agent, no other drugs were given through this cannula. In groups A and C, anaesthesia was induced with propofol 2.5 mg kg" 1 and maintained with 67 % nitrous oxide in oxygen via a Magill breathing system and mask, supplemented by increments of propofol 10-20 mg when indicated clinically. In group B, patients received Althesin 50 ng kg" 1 for induction, and 1-ml increments of Althesin were given to supplement the nitrous oxide in oxygen. In group D, thiopentone was used as the induction agent, and anaesthesia was maintained with 1-1.5% halothane, plus nitrous oxide in oxygen. At the end of surgery, the nitrous oxide (and halothane) were discontinued. The duration of anaesthesia was recorded, together with two indices of recovery: time from cessation of nitrous oxide to opening eyes on command, and the time taken to giving correct date of birth.
All side effects occurring during induction, maintenance and recovery from anaesthesia were noted: in particular, patients were questioned about pain associated with the induction of anaesthesia, and any evidence of phlebitis or venous thrombosis at the site of drug administration was sought during the 24 h immediately following anaesthesia.
During the operation, the electrocardiogram was monitored continuously using leads in the CM 6 configuration, and the arterial pressure was measured during induction, and then at 5-min intervals during anaesthesia and surgery, using a Copal automatic arterial pressure recorder and printer (Copal Digital Sphygmomanometer UA-251).
Biochemical and naematological investigations
In each patient, three samples of blood were withdrawn from a cannula in the antecubital fossa contralateral to the side of drug administration: before the induction of anaesthesia, and at 30 min and 3 h following induction. Cortisol concentrations were determined by radioimmunoassay and glucose concentrations (Beckman glucose analyser) in a separate sample taken into sodium oxalate.
In the first 20 patients (groups A and B), additional naematological and coagulation indices were measured before induction, and at 30 min after the onset of anaesthesia. Five millilitre of blood were collected into EDTA for full blood count including platelets, 1 ml into citrate for coagulation studies (prothrombin time, partial thromboplastin time, thrombin titre, fibrinogen titre), and 1 ml into a trasylol tube for determination of fibrin degradation products (FDP).
Statistical analyses
Duration of anaesthesia and haematological indices were compared using the Student's paired t test within treatment groups, and the unpaired t test between groups. Recovery times were subjected to logarithmic transformation to correct for a positive skewness and then compared between groups by the Student's t test. Dose requirements in the propofol and Althesin groups were determined by regression analyses. The incidence of side effects within the individual groups was compared using either the Fisher exact probability test, or x 1 with Yates' correction for small numbers. The changes in glucose and cortisol concentrations were compared within a study group by the Wilcoxon matched pairs signed rank test. 
RESULTS
Forty-one patients (21 male) aged 18-65 yr and weighing between 47.7 and 89.0 kg were studied. Their demographic details, total doses of drug administered, and duration of anaesthesia are shown in table I. Anaesthesia was uneventful in 40 of the patients studied. In one patient, receiving propofol, there was a significant decrease in systolic arterial pressure following the induction of anaesthesia (from 170 to 60 mm Hg). This was treated by the administration of fluids i.v., and ventilation (via a tracheal tube) with 100 % oxygen until the arterial pressure had returned to its baseline value. No postoperative sequelae were observed. The incidence of side effects in the remaining 40 patients was low (table II) even with the data from groups A and C (propofol) being combined. Spontaneous involuntary movements were seen in nine patients (five received propofol and four Althesin). There was a significantly greater incidence (P < 0.008) of mild or moderate pain on injection in patients receiving propofol. Eight patients receiving propofol had a period of apnoea of greater than 30 s following induction of anaesthesia (P < 0.016 compared with thiopentone).
The cardiovascular responses to anaesthesia and surgery were compared between the groups of patients. If the propofol groups are considered together, the induction of anaesthesia resulted in a 22 % decrease in systolic arterial pressure, a 16 % decrease in diastolic arterial pressure, and no significant change in heart rate. For comparison, the data for patients in groups A-D are shown in table III. During stable anaesthesia before the start of surgery, cardiovascular depression was greatest in the patients receiving nitrous oxideoxygen-halothane anaesthesia (group D). The response to surgery, assessed 5 min after incision, was also greatest in this group of patients. Recovery, as measured by the time to giving correct date of birth, was significantly faster in the patients receiving propofol (group A) (P < 0.05) (table IV). The exact time to recovery was not recorded in groups C and D (propofol and halothane, respectively). However, when assessed overall, only two of the patients receiving propofol had not recovered sufficiently by 10 min after the discontinuation of anaesthesia to give their correct date of birth. This was significantly better than the patients in group D (halothane) (P < 0.001). There was no correlation between total dose of propofol administered and the achievement of either of the chosen end-points of recovery. The overall maintenance rate for group B (Althesin) was alphaxalone 23.1 ng kg" 1 min" 1 (95% confidence limits: 9.3-57.0), and for groups A and C together (propofol) diisopropyl phenol 73.4 \xg kg" 1 min" 1 (32.3-167.1). There was no significant difference in dose requirements between male and female patients receiving propofol.
• There was no significant change in any of the haematological or coagulation variables measured in patients in groups A and B, and no immediate postoperative venous sequelae were observed.
Glucose and cortisol concentrations were analysed in 40 patients (table V). One of the patients receiving propofol (group C) was receiving intercurrent steroid therapy and was, therefore, given hydrocortisone 100 mg as part of the premedication. Cortisol concentrations were not measured in this patient.
The plasma glucose concentrations in groups A, B and C increased significantly during surgery, and returned towards their pre-induction values by 3 h. The increase in glucose concentration in group D (halothane) did not reach statistical significance.
There were, similarly, differences between the groups in the cortisol response to anaesthesia and surgery. All four groups showed considerable inter-individual variability. In group D, there was a decrease in the cortisol concentration in the TABLE V. Plasma glucose and cortisol concentrations in the four study groups. Samples were collected before induction of anaesthesia {sample 1); 30 min after induction {sample 2); and 3 h after induction {sample 3). {Data shown as mean ± SEM, and compared between samples using the Wilcoxon matched pairs signed ranks test, and between groups by the Whitney-Mann U test). Comparison within groups: *P < 0.05; tP < 0.025; **P < 0.01; ***P < 0.001. There were no differences between groups A and B, and C and D, with regard to the glucose or cortisol concentrations at any of the sampling points 30-min sample, but this did not reach statistical significance. However, in groups A, B and C, the decreases at this time point were significant (P < 0.05, P < 0.05 and P < 0.01, respectively.) By the 3-h samples, the cortisol concentrations in all groups were not significantly altered from their baseline (pre-induction) values. This was the result of some patients showing an increase and some a decrease in cortisol concentration in this third sample when compared with their basal value. There were no significant differences between the groups in the glucose or cortisol concentrations at any of the three sampling times.
Group
DISCUSSION
We have previously reported the ED 96 induction dose of diisopropyl phenol formulated in intralipid (propofol) to be 2.5 mg kg" 1 (Cummings et al., 1984) . This dose was used successfully for the induction of anaesthesia in all patients in this study. When given by increments to supplement 67 % nitrous oxide in oxygen, propofol provided satisfactory anaesthesia with rapid and complete recovery. Although the two recovery criteria chosen are crude indices of patient performance, there was a significant difference between patients receiving propofol and those receiving Althesin. Just as with Althesin, we have been unable to find any relationship between time to recovery and total dose of propofol administered (Prys-Roberts and Sear, 1984) .
The maintenance rate of administration in our patients, 73.4 |jg kg" 1 min" 1 , was comparable to that reported using the previous Cremophor formulation ( Prys-Roberts, Sear and Adam, 1981) , but less than that described by Major and colleagues (1982) . However, our mean rate will approximate more closely to the minimum infusion rate (MIR) (ED 60 ) of Prys-Roberts than to those used by Major. The wide range of results in our patients (38-155 v% kg" 1 min" 1 ) reflects the rapidly changing blood concentrations of the drug, and hence depth of anaesthesia, associated with repeat bolus doses-rather than the stable blood concentrations achieved with a continuous infusion. Whether the reformulation in intralipid will result in changes in the bioavailability of the active drug, as indicated by increased induction dose requirements, and an increased MIR, remains to be determined.
The cardiovascular responses to induction of anaesthesia, and to the initial surgical incision in patients receiving propofol or Althesin were similar to those reported previously for i.v. anaesthetic agents (Prys-Roberts, 1982 , 1984 . In group D (halothane), the induction of anaesthesia and steady state anaesthesia in the absence of surgery were accompanied by significant decreases in mean arterial pressure and heart rate. These changes have been observed by other authors (Prys-Roberts et al., 1974) . The magnitude of the cardiovascular response to surgery was greatest in our group of patients maintained with halothane.
It was hoped that the change of solvent would decrease the incidence of unwanted side effects and adverse reactions to diisopropyl phenol seen with the Cremophor formulation. One of the major side effects was a high incidence of pain on injection: up to 50% if injected in a vein on the dorsum of the hand. The results of this study, where nine of 20 patients complained of pain, would suggest that the reformulation in intralipid has not removed this problem. Similarly, the higher induction dose was associated with apnoea of greater than 30 s in eight patients. This is higher than in our earlier studies (Cummings et al., 1984) ; however, in this study the patients were premedicated with morphine, the patients in the earlier study having been unpremedicated. The one example of marked arterial hypotension following induction of anaesthesia remains the major unsatisfactory side effect of the drug noted in this study. Apart from the decrease in arterial pressure, there was no associated increase in heart rate, and no other sequelae to suggest a true anaphylactic reaction (for example flushing, periorbital oedema). It is probable, therefore, that the patient was of the group of individuals with untreated labile hypertension, as his arterial pressure on admission was within normal limits. The cardiovascular effects seen on induction of anaesthesia with propofol in this man were comparable to those reported by Prys-Roberts, Meloche and Foex (1971) and other induction agents, and emphasize the need for adequate monitoring during anaesthesia in these patients.
There have been reports that the administration of intralipid could result in in vivo alterations of blood coagulation (Amris, Brockner and Larsen, 1964 ). This has not been confirmed by the dose of 10 % intralipid (maximum 53 ml) given to patients in this study. Indeed, we found no difference in the indices of coagulation and fibrinolysis within the two groups of patients investigated; nor any incidence of venous sequelae, in the patients who received propofol, when studied over the first 24 h after surgery.
The neuro-endocrine responses to anaesthesia and surgery in our patients receiving thiopentone, nitrous oxide and halothane were broadly comparable to those described by Clarke, Johnston and Sheridan (1970) for patients undergoing body surface surgery. However, whereas the patients receiving propofol showed the expected hyperglycaemic response, there were significant initial decreases in the plasma cortisol concentration. By 3 h after induction, there was no continued depression of the cortisol concentration-as has been reported for up to 24 h in patients receiving etomidate for the induction (and maintenance) of anaesthesia (Wagner et al., 1984; Moore et al., 1985) . The exact reason for the differences between the patients receiving i.v. anaesthesia (groups A to C) and those receiving halothane is not known at present. Whether further sampling would have shown the expected increase in cortisol concentration in all patients is not known, but there is no clear factor by which we could separate those patients in whom the cortisol concentration increased and those in whom it decreased.
Subsequent studies with propofol by continuous infusion should include further investigation of its effects on neuro-endocrine function. However, to date the profile of the drug has shown it to be a possible alternative to volatile agents as a supplement to nitrous oxide in oxygen anaesthesia.
